Regen BioPharma (Regen BioPharma) 3-Year EPS without NRI Growth Rate : 29.60% (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Regen BioPharma 3-Year EPS without NRI Growth Rate?

Regen BioPharma's EPS without NRI for the three months ended in Mar. 2024 was $-0.03.

During the past 12 months, Regen BioPharma's average EPS without NRI Growth Rate was -108.60% per year. During the past 3 years, the average EPS without NRI Growth Rate was 29.60% per year. During the past 5 years, the average EPS without NRI Growth Rate was 62.70% per year. During the past 10 years, the average EPS without NRI Growth Rate was 47.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 11 years, the highest 3-Year average EPS without NRI Growth Rate of Regen BioPharma was 79.20% per year. The lowest was -16.60% per year. And the median was 44.90% per year.

Competitive Comparison of Regen BioPharma's 3-Year EPS without NRI Growth Rate

For the Biotechnology subindustry, Regen BioPharma's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Regen BioPharma's 3-Year EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Regen BioPharma's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Regen BioPharma's 3-Year EPS without NRI Growth Rate falls into.

Regen BioPharma 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

Regen BioPharma (OTCPK:RGBP) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.

Regen BioPharma 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Regen BioPharma's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Regen BioPharma (Regen BioPharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Regen BioPharma Inc (OTCPK:RGBP) » Definitions » 3-Year EPS without NRI Growth Rate

Comparable Companies

Traded in Other Exchanges

RGBPP.PFD:USA

Address

4700 Spring Street, Suite 304, La Mesa, CA, USA, 91942

Website

https://www.regenbiopharmainc.com

Regen BioPharma Inc is a US-based biotechnology company. It focuses on the development of regenerative medical applications in the stem cell space. The company's principal products and services include HemaXellarate I, HemaXellerate II, dCell Vax, NR2F6, Tcellvax, identification of Small Molecules, and others. HemaXellarate I and HemaXellerate II is a cellular therapy designed to heal damaged bone marrow. dCell Vax is a therapy whereby dendritic cells of the cancer patient are harvested from the body. Tcellvax is an autologous cellular product comprised of NR2F6 gene-silenced peripheral blood mononuclear cells.